 | • レポートコード：MRC2-11QY12520 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脂質異常症治療の競争状況、市場シェア ・世界の脂質異常症治療市場：種類別市場規模 2015年-2020年（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤） ・世界の脂質異常症治療市場：種類別市場規模予測 2021年-2026年（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤） ・世界の脂質異常症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の脂質異常症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の脂質異常症治療市場分析：米国、カナダ ・ヨーロッパの脂質異常症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脂質異常症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脂質異常症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脂質異常症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceuticals、Mylan Pharmaceuticals、Kowa Pharmaceuticals、Glenmark Pharmaceuticals、Sun Pharmaceuticals、Wockhardt Limited. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,.
Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., and Wockhardt Limited.
Market Analysis and Insights: Global Lipid Disorder Treatment Market
The global Lipid Disorder Treatment market size is projected to reach US$ 21560 million by 2026, from US$ 20160 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Lipid Disorder Treatment Scope and Market Size
Lipid Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lipid Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva Pharmaceuticals
Mylan Pharmaceuticals
Kowa Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceuticals
Wockhardt Limited.
…
Market segment by Type, the product can be split into
Atorvastatin
Fluvastatin
Rosuvastatin
Simvastatin
Pravastatin
Other Drugs
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lipid Disorder Treatment Revenue
1.4 Market by Type
1.4.1 Global Lipid Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Atorvastatin
1.4.3 Fluvastatin
1.4.4 Rosuvastatin
1.4.5 Simvastatin
1.4.6 Pravastatin
1.4.7 Other Drugs
1.5 Market by Application
1.5.1 Global Lipid Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lipid Disorder Treatment Market Perspective (2015-2026)
2.2 Global Lipid Disorder Treatment Growth Trends by Regions
2.2.1 Lipid Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lipid Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Lipid Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lipid Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Lipid Disorder Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lipid Disorder Treatment Players by Market Size
3.1.1 Global Top Lipid Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global Lipid Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Lipid Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lipid Disorder Treatment Market Concentration Ratio
3.2.1 Global Lipid Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lipid Disorder Treatment Revenue in 2019
3.3 Lipid Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Lipid Disorder Treatment Product Solution and Service
3.5 Date of Enter into Lipid Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lipid Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Lipid Disorder Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lipid Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Lipid Disorder Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lipid Disorder Treatment Market Size (2015-2020)
6.2 Lipid Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Lipid Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Lipid Disorder Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lipid Disorder Treatment Market Size (2015-2020)
7.2 Lipid Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Lipid Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Lipid Disorder Treatment Market Size by Application (2015-2020)
8 China
8.1 China Lipid Disorder Treatment Market Size (2015-2020)
8.2 Lipid Disorder Treatment Key Players in China (2019-2020)
8.3 China Lipid Disorder Treatment Market Size by Type (2015-2020)
8.4 China Lipid Disorder Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lipid Disorder Treatment Market Size (2015-2020)
9.2 Lipid Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Lipid Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Lipid Disorder Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lipid Disorder Treatment Market Size (2015-2020)
10.2 Lipid Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lipid Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Lipid Disorder Treatment Market Size by Application (2015-2020)
11 India
11.1 India Lipid Disorder Treatment Market Size (2015-2020)
11.2 Lipid Disorder Treatment Key Players in India (2019-2020)
11.3 India Lipid Disorder Treatment Market Size by Type (2015-2020)
11.4 India Lipid Disorder Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lipid Disorder Treatment Market Size (2015-2020)
12.2 Lipid Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Lipid Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Lipid Disorder Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Details
13.1.2 Teva Pharmaceuticals Business Overview
13.1.3 Teva Pharmaceuticals Lipid Disorder Treatment Introduction
13.1.4 Teva Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020))
13.1.5 Teva Pharmaceuticals Recent Development
13.2 Mylan Pharmaceuticals
13.2.1 Mylan Pharmaceuticals Company Details
13.2.2 Mylan Pharmaceuticals Business Overview
13.2.3 Mylan Pharmaceuticals Lipid Disorder Treatment Introduction
13.2.4 Mylan Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020)
13.2.5 Mylan Pharmaceuticals Recent Development
13.3 Kowa Pharmaceuticals
13.3.1 Kowa Pharmaceuticals Company Details
13.3.2 Kowa Pharmaceuticals Business Overview
13.3.3 Kowa Pharmaceuticals Lipid Disorder Treatment Introduction
13.3.4 Kowa Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020)
13.3.5 Kowa Pharmaceuticals Recent Development
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Details
13.4.2 Glenmark Pharmaceuticals Business Overview
13.4.3 Glenmark Pharmaceuticals Lipid Disorder Treatment Introduction
13.4.4 Glenmark Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020)
13.4.5 Glenmark Pharmaceuticals Recent Development
13.5 Sun Pharmaceuticals
13.5.1 Sun Pharmaceuticals Company Details
13.5.2 Sun Pharmaceuticals Business Overview
13.5.3 Sun Pharmaceuticals Lipid Disorder Treatment Introduction
13.5.4 Sun Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020)
13.5.5 Sun Pharmaceuticals Recent Development
13.6 Wockhardt Limited.
13.6.1 Wockhardt Limited. Company Details
13.6.2 Wockhardt Limited. Business Overview
13.6.3 Wockhardt Limited. Lipid Disorder Treatment Introduction
13.6.4 Wockhardt Limited. Revenue in Lipid Disorder Treatment Business (2015-2020)
13.6.5 Wockhardt Limited. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lipid Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Lipid Disorder Treatment Revenue
Table 3. Ranking of Global Top Lipid Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lipid Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Atorvastatin
Table 6. Key Players of Fluvastatin
Table 7. Key Players of Rosuvastatin
Table 8. Key Players of Simvastatin
Table 9. Key Players of Pravastatin
Table 10. Key Players of Other Drugs
Table 11. Global Lipid Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Lipid Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Lipid Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Lipid Disorder Treatment Market Share by Regions (2015-2020)
Table 15. Global Lipid Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Lipid Disorder Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Lipid Disorder Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Lipid Disorder Treatment Players
Table 22. Global Lipid Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Lipid Disorder Treatment Market Share by Players (2015-2020)
Table 24. Global Top Lipid Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lipid Disorder Treatment as of 2019)
Table 25. Global Lipid Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Lipid Disorder Treatment Product Solution and Service
Table 28. Date of Enter into Lipid Disorder Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Lipid Disorder Treatment Market Size Share by Type (2015-2020)
Table 32. Global Lipid Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Lipid Disorder Treatment Market Size Share by Application (2015-2020)
Table 34. Global Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Lipid Disorder Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 38. North America Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 40. North America Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 44. Europe Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 46. Europe Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 50. China Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 52. China Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 56. Japan Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 58. Japan Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 62. Southeast Asia Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 68. India Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 70. India Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Lipid Disorder Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Lipid Disorder Treatment Market Share (2019-2020)
Table 74. Central & South America Lipid Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Lipid Disorder Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Lipid Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Lipid Disorder Treatment Market Share by Application (2015-2020)
Table 78. Teva Pharmaceuticals Company Details
Table 79. Teva Pharmaceuticals Business Overview
Table 80. Teva Pharmaceuticals Product
Table 81. Teva Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 82. Teva Pharmaceuticals Recent Development
Table 83. Mylan Pharmaceuticals Company Details
Table 84. Mylan Pharmaceuticals Business Overview
Table 85. Mylan Pharmaceuticals Product
Table 86. Mylan Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 87. Mylan Pharmaceuticals Recent Development
Table 88. Kowa Pharmaceuticals Company Details
Table 89. Kowa Pharmaceuticals Business Overview
Table 90. Kowa Pharmaceuticals Product
Table 91. Kowa Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 92. Kowa Pharmaceuticals Recent Development
Table 93. Glenmark Pharmaceuticals Company Details
Table 94. Glenmark Pharmaceuticals Business Overview
Table 95. Glenmark Pharmaceuticals Product
Table 96. Glenmark Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 97. Glenmark Pharmaceuticals Recent Development
Table 98. Sun Pharmaceuticals Company Details
Table 99. Sun Pharmaceuticals Business Overview
Table 100. Sun Pharmaceuticals Product
Table 101. Sun Pharmaceuticals Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 102. Sun Pharmaceuticals Recent Development
Table 103. Wockhardt Limited. Company Details
Table 104. Wockhardt Limited. Business Overview
Table 105. Wockhardt Limited. Product
Table 106. Wockhardt Limited. Revenue in Lipid Disorder Treatment Business (2015-2020) (Million US$)
Table 107. Wockhardt Limited. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lipid Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. Atorvastatin Features
Figure 3. Fluvastatin Features
Figure 4. Rosuvastatin Features
Figure 5. Simvastatin Features
Figure 6. Pravastatin Features
Figure 7. Other Drugs Features
Figure 8. Global Lipid Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Lipid Disorder Treatment Report Years Considered
Figure 13. Global Lipid Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Lipid Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Lipid Disorder Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Lipid Disorder Treatment Market Share by Players in 2019
Figure 18. Global Top Lipid Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lipid Disorder Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Lipid Disorder Treatment Revenue in 2019
Figure 20. North America Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Lipid Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
ENT疾患治療の世界市場（～2026年） ENT is a medical abbreviation for ears, nose and throat. Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. Market Analysis and Insights: Global ENT Disorder Treatment Market The global ENT Disorder Treatment market size is projected to rea…- 季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
- 甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
- 自閉症スペクトラム障害（ASD）治療の世界市場（～2026年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…
- 認知症・運動障害治療の世界市場（～2026年） Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…